Kaufmann Petra 4
4 · Vigil Neuroscience, Inc. · Filed Mar 20, 2024
Insider Transaction Report
Form 4
Kaufmann Petra
Chief Medical Officer
Transactions
- Award
Stock Option Grant (Right to Buy)
2024-03-18+330,000→ 330,000 totalExercise: $3.14Exp: 2034-03-18→ Common Stock (330,000 underlying)
Footnotes (1)
- [F1]This stock option award was issued subject to the terms of the Issuer's 2021 Stock Option and Incentive Plan and shall vest as follows: 25% of the shares shall be vested on March 18, 2025 and 1/36th of the remaining shares shall vest on each monthly anniversary thereafter.